These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27836438)

  • 1. What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countries.
    Kristensen DD; Bartholomew K; Villadiego S; Lorenson K
    Vaccine; 2016 Dec; 34(50):6236-6242. PubMed ID: 27836438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
    Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
    Mvundura M; Frivold C; Janik Osborne A; Soni P; Robertson J; Kumar S; Anena J; Gueye A; Menozzi-Arnaud M; Giersing B; Kahn AL; Scarna T; Kristensen D
    Vaccine; 2021 Dec; 39(49):7195-7207. PubMed ID: 34412922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.
    Haidari LA; Wahl B; Brown ST; Privor-Dumm L; Wallman-Stokes C; Gorham K; Connor DL; Wateska AR; Schreiber B; Dicko H; Jaillard P; Avella M; Lee BY
    Vaccine; 2015 Jun; 33(28):3242-7. PubMed ID: 25889160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
    Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
    Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine wastage in Ghana, Mozambique, and Pakistan: An assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage.
    Mvundura M; Ng J; Reynolds K; Theng Ng Y; Bawa J; Bambo M; Bonsu G; Payne J; Chua J; Guerette J; Odei Antwi-Agyei K; Ribe S; Chinavane D; Arhin-Wiredu K; Shah A; Sitoe J; Yunus S; Powelson J; Amponsa-Achiano K; Eshioramhe Kojak K; Fredick Dadzie J; Asghar N; Caetano Correa G; Robertson J
    Vaccine; 2023 Jun; 41(28):4158-4169. PubMed ID: 37270365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vaccine adoption in lower-middle-income countries.
    Makinen M; Kaddar M; Molldrem V; Wilson L
    Health Policy Plan; 2012 May; 27 Suppl 2():ii39-49. PubMed ID: 22513731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The imperative for stronger vaccine supply and logistics systems.
    Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
    Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
    Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
    Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
    Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
    Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence.
    Heaton A; Krudwig K; Lorenson T; Burgess C; Cunningham A; Steinglass R
    Vaccine; 2017 Apr; 35(17):2272-2278. PubMed ID: 28162822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of tailoring vial sizes to populations and locations.
    Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
    Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine procurement and self-sufficiency in developing countries.
    Woodle D
    Health Policy Plan; 2000 Jun; 15(2):121-9. PubMed ID: 10837034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
    Drain PK; Nelson CM; Lloyd JS
    Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries.
    Karp CL; Lans D; Esparza J; Edson EB; Owen KE; Wilson CB; Heaton PM; Levine OS; Rao R
    Vaccine; 2015 Jul; 33(30):3471-9. PubMed ID: 26055297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries.
    Basu S; Rustagi R
    Hum Vaccin Immunother; 2022 Nov; 18(6):2059310. PubMed ID: 35416750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
    Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.